KLIKZEMPIC

Purity

99.5%

Mol. Weight

4113.58 Da

Form

Prefilled Klik-Pen

Amino Acid Sequence

Modified GLP-1(7-37) analogue

KLIKZEMPIC contains semaglutide, a long-acting GLP-1 receptor agonist with 94% structural homology to native GLP-1. Each pen contains 8mg/3ml (4 doses of 2mg). An amino acid substitution at position 8 and a C-18 fatty di-acid chain enable albumin binding, extending the half-life to approximately 7 days. Research focuses on glycemic control, appetite regulation, cardiovascular risk reduction, and neuroinflammation pathways.

Available Variants

SKU	Dosage	Price (AED)	Status
SMA-1PEN	8mg	AED 695	AVAILABLE
SMA-3PK	3x8mg	AED 1,875	AVAILABLE

Research Use Only. All products listed on this platform are intended solely for in-vitro research and laboratory use. They are not intended for human or animal consumption, medical diagnosis, or therapeutic application. By accessing this site, you confirm you are a qualified researcher or authorized procurement agent. No statements have been evaluated by any regulatory authority. Purchasers assume all responsibility for compliance with applicable local, national, and international regulations.